Today, the CannaMex World Summit was hosted in Guanajuato from May 31 to address the opportunities for the use of cannabis in the fields of science, research, medicine, government, technology, innovation and agro-industry in Mexico. Through high-level conferences, the Summit provided debate on issues related to international experiences, legislation, uses, impacts, benefits, medical evidence, potential markets and taboos about cannabis.
CannaMex had 34 recognized figures presenting from around the world, but the presence of the American continent was predominant with 32 percent of the speakers coming from LATAM, 11 percent from North America, 50 percent from Mexico and the rest from the other continents.
The 2018 report on medicinal cannabis by the International Drug Policy Consortium, says LATAM is the most advanced region with regulations and policies for the use of medicinal cannabis. However, the absence of international and regional standards has made the process of regulation within LATAM to differ from country to country. While in Mexico, Argentina and Brazil the regulation of medicinal cannabis was a result of civil society initiatives to import medicines, in Uruguay was the result of a government initiative that allows the legal and recreational use of cannabis.
There are more than 22,000 publications, of which 50 percent have been published in the last 10 years, on the medicinal properties of cannabis and cannabinoids in the US, says the book Cannabis: A Clinical Guide. The book says the medicinal properties of cannabis have potential in dealing with memory disorders and depression but also benefit the brain functioning and harness the endocannabinoid system (ECS).
Also, the hemp can be used for industrial purposes. A study from the University of Texas says the hemp can be used for developing hemp concrete, fiberboard and insulation, which are considered to be environmental-friendly and economic building materials. However, hemp regulations and policies on cultivation, processing and commercialization still hinder the development of this industry, says the research.
Meanwhile, in Mexico regulation for the medicinal use of cannabis continues to be revised by the Federal Commission for Regulatory Improvement (COFEMER) and the Federal Commission for Protection against Health Risks (COFEPRIS). This regulation, according to both authorities will open the door to national and international companies in developing a hemp industry for medicinal and industrial use in the country.
Industry Analyst and Journalist at Mexico Business Publishing